Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Alvogen
Alvogen
Activities:
Regulatory
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Finance
Alvogen partners with Kinaxis on supply chain management
Kinaxis will help Alvogen effectively manage its product introduction and tender processes to determine project feasibility and impact across the supply chain
Distribution
Dipharma and Alvogen launch Diterin in South Korea
First drug commercially available for the treatment of hyperphenylalaninemia due to phenylketonuria
Finance
CVC Capital Partners leads consortium to acquire controlling stake in Alvogen
Consortium will provide funds to help Alvogen become a leading generics player worldwide
Finance
Alvogen acquires Dream Pharma of Korea for US$187m
Third significant acquisition for the company in the Asia-Pacific region since 2012
Manufacturing
Alvotech invests US$250m in biopharmaceuticals
Portfolio of biosimilar products to be marketed by sister company, Alvogen
Ingredients
Alvogen expands its operations in India
Clinical service and API sourcing capabilities established
Subscribe now